MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1001/archderm.140.7.827

Медицинская библиотека · Archives of dermatology · 2004

Effects of a superpotent melanotropic peptide in combination with solar UV radiation on tanning of the skin in human volunteers.

Dorr Robert T, Ertl Gregory, Levine Norman, Brooks Chris, Bangert Jerry L, Powell Marianne Broome, Humphrey Stuart, Alberts David S

Клиническое исследованиеКлиническое исследование I фазыСтатьяРандомизированное исследованиеПоддержка службы здравоохранения СШАПеревод пока не подготовлен

Аннотация

OBJECTIVE

Three phase 1 clinical trials of a superpotent melanotropic peptide, melanotan-1 (MT-1, or [Nle(4)-D-Phe(7)]alpha-melanocyte-stimulating hormone) were performed to demonstrate safety for MT-1 therapy combined with UV-B light or sunlight.

DESIGN

Open-label studies at 2 dose levels of MT-1 combined with small doses of UV-B to the neck or buttock or full sunlight to half of the back.

SETTING

Dermatology clinics at the Arizona Health Sciences Center, Tucson.

INTERVENTIONS: The first study randomized 4 subjects to MT-1 (0.08 mg/kg per day subcutaneously) and 4 subjects to injections of isotonic sodium chloride (9%) solution for 10 days, followed by neck irradiation with 3 times the minimal erythema dose (MED) of UV-B light. In the next study (n = 12), the MT-1 dosage was increased to 0.16 mg/kg per day for 10 days, with UV-B radiation (0.25-0.75 MED) given to a buttock site for 5 days during (n = 7) or after (n = 5) MT-1 administration. A final study randomized 8 subjects to 3 to 5 days of sunlight to half of the back or to sunlight plus 0.16 mg/kg of MT-1 for 5 days per week for 4 weeks.

RESULTS

Tanning in the first study was achieved in 3 of 4 subjects receiving MT-1, and these subjects also had 47% fewer sunburn cells at the irradiated neck site. More skin sites darkened with the higher dose of MT-1 in the second study. In the third study, there was significantly enhanced tanning of the back in the MT-1 group, and this was maintained at least 3 weeks longer than the tanning in the sunlight-only controls, who required 50% more sun-exposure time for equivalent tanning.

MAIN OUTCOME MEASURE: There were no pathologic findings at any UV-B or sun-exposed sites in any subject. Toxic effects due to MT-1 were minor, consisting of nausea and transient facial flushing.

CONCLUSION

Melanotan-1 can be safely combined with UV-B light or sunlight and appears to act synergistically in the tanning response to light.

Для цитирования: Dorr Robert T, Ertl Gregory, Levine Norman, Brooks Chris, Bangert Jerry L, Powell Marianne Broome, Humphrey Stuart, Alberts David S. Effects of a superpotent melanotropic peptide in combination with solar UV radiation on tanning of the skin in human volunteers.. Archives of dermatology. 2004. DOI: 10.1001/archderm.140.7.827.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.